By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Infectious Disease Research Institute (IDRI) 

1124 Columbia Street
Suite 400
Seattle  Washington  98104  U.S.A.
Phone: 206-381-0883 Fax: 206-381-3678


SEARCH JOBS








Company News
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/20/2014 6:09:18 AM
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/19/2014 11:36:35 AM
Infectious Disease Research Institute (IDRI) and Zydus Sign Agreement for Development of IDRI's Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar) 7/25/2013 9:52:03 AM
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine 4/18/2013 9:23:50 AM
Infectious Disease Research Institute (IDRI) and Medicago, Inc. to Present Data at the World Vaccine Congress 4/9/2013 6:48:19 AM
Infectious Disease Research Institute (IDRI) and Medicago, Inc. Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine With GLA Adjuvant 8/16/2012 10:20:05 AM
Infectious Disease Research Institute (IDRI) Expands Board, Adding Additional International Expertise With Dr Massimo Radaelli 7/3/2012 9:59:17 AM
Soligenix (SNGX.OB) Announces Collaboration with Infectious Disease Research Institute (IDRI) to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants 6/27/2012 9:40:52 AM
Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters 5/31/2012 11:10:18 AM
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine 5/10/2012 10:06:47 AM
12345
//-->